A detailed history of M&T Bank Corp transactions in Johnson & Johnson stock. As of the latest transaction made, M&T Bank Corp holds 1,997,047 shares of JNJ stock, worth $292 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares
1,997,047
Previous 2,049,336 2.55%
Holding current value
$292 Million
Previous $321 Million 1.65%
% of portfolio
1.11%
Previous 1.18%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$155.22 - $162.74 $8.12 Million - $8.51 Million
-52,289 Reduced 2.55%
1,997,047 $316 Million
Q4 2023

Feb 06, 2024

SELL
$145.6 - $158.88 $4.3 Million - $4.69 Million
-29,514 Reduced 1.42%
2,049,336 $321 Million
Q3 2023

Nov 02, 2023

SELL
$155.75 - $174.48 $12.1 Million - $13.6 Million
-77,940 Reduced 3.61%
2,078,850 $324 Million
Q2 2023

Aug 09, 2023

SELL
$154.35 - $166.11 $3.82 Million - $4.11 Million
-24,765 Reduced 1.14%
2,156,790 $357 Million
Q1 2023

May 11, 2023

SELL
$151.05 - $180.26 $2.73 Million - $3.26 Million
-18,073 Reduced 0.82%
2,181,555 $338 Million
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $15 Million - $16.8 Million
93,439 Added 4.44%
2,199,860 $389 Million
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $37,166 - $41,711
-232 Reduced 0.01%
2,199,628 $389 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $6.47 Million - $7.2 Million
40,096 Added 1.94%
2,106,421 $339 Million
Q2 2022

Aug 05, 2022

BUY
$168.19 - $186.01 $39.3 Million - $43.5 Million
233,682 Added 12.75%
2,066,325 $336 Million
Q1 2022

May 09, 2022

SELL
$158.14 - $179.59 $12.6 Million - $14.4 Million
-79,935 Reduced 4.18%
1,832,643 $325 Million
Q4 2021

Feb 07, 2022

SELL
$155.93 - $173.01 $3.69 Million - $4.1 Million
-23,674 Reduced 1.22%
1,912,578 $327 Million
Q3 2021

Oct 28, 2021

SELL
$161.5 - $179.47 $5.48 Million - $6.08 Million
-33,905 Reduced 1.72%
1,936,252 $313 Million
Q2 2021

Aug 13, 2021

SELL
$159.48 - $171.07 $12.2 Million - $13.1 Million
-76,384 Reduced 3.73%
1,970,157 $325 Million
Q1 2021

May 06, 2021

SELL
$153.07 - $170.48 $939,084 - $1.05 Million
-6,135 Reduced 0.3%
2,046,541 $336 Million
Q4 2020

Feb 12, 2021

SELL
$137.11 - $157.38 $2.74 Million - $3.15 Million
-20,012 Reduced 0.97%
2,052,676 $323 Million
Q3 2020

Nov 06, 2020

SELL
$140.38 - $153.83 $3.14 Million - $3.44 Million
-22,364 Reduced 1.07%
2,072,688 $309 Million
Q2 2020

Jul 29, 2020

SELL
$128.81 - $155.51 $5.02 Million - $6.06 Million
-39,000 Reduced 1.83%
2,095,052 $295 Million
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $4.22 Million - $5.84 Million
-37,951 Reduced 1.75%
2,134,052 $280 Million
Q4 2019

Feb 07, 2020

SELL
$127.5 - $146.44 $5.27 Million - $6.06 Million
-41,357 Reduced 1.87%
2,172,003 $317 Million
Q3 2019

Nov 12, 2019

SELL
$126.95 - $142.14 $4.39 Million - $4.92 Million
-34,610 Reduced 1.54%
2,213,360 $286 Million
Q2 2019

Aug 12, 2019

SELL
$131.15 - $144.24 $3.91 Million - $4.3 Million
-29,837 Reduced 1.31%
2,247,970 $313 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $4.09 Million - $4.55 Million
-32,529 Reduced 1.41%
2,277,807 $318 Million
Q4 2018

Feb 01, 2019

SELL
$122.84 - $147.84 $10 Million - $12 Million
-81,378 Reduced 3.4%
2,310,336 $298 Million
Q3 2018

Nov 09, 2018

SELL
$121.58 - $142.88 $4.93 Million - $5.79 Million
-40,525 Reduced 1.67%
2,391,714 $330 Million
Q2 2018

Aug 10, 2018

SELL
$119.4 - $131.76 $421,601 - $465,244
-3,531 Reduced 0.14%
2,432,239 $295 Million
Q1 2018

May 04, 2018

BUY
$125.1 - $148.14 $855,433 - $1.01 Million
6,838 Added 0.28%
2,435,770 $312 Million
Q4 2017

Feb 06, 2018

SELL
$131.22 - $143.62 $6.71 Million - $7.34 Million
-51,098 Reduced 2.06%
2,428,932 $339 Million
Q3 2017

Nov 13, 2017

SELL
$129.47 - $135.38 $1.62 Million - $1.69 Million
-12,504 Reduced 0.5%
2,480,030 $322 Million
Q2 2017

Aug 11, 2017

BUY
N/A
2,492,534
2,492,534 $330 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.